Skip to main content
. 2023 Aug 14;14(4):1837–1848. doi: 10.21037/jgo-23-486

Figure 1.

Figure 1

Flowchart of patient inclusion and outcomes. HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; TKI, tyrosine kinase inhibitor; ICI, immune checkpoint inhibitor; ECOG, Eastern Cooperative Oncology Group.